share_log

Market-Moving News for December 10th

Market-Moving News for December 10th

影響市場的資訊,日期爲12月10日
Benzinga ·  2024/12/10 20:32

LLY: 1.5% | Eli Lilly Reports Results From Phase 3 BRUIN CLL-321 Trial Evaluating Pirtobrutinib; Study's Primary Endpoint Of Progression-Free Survival Was Met At Primary Analysis; announces $15B share repurchase program, 15% dividend increase

LLY: 1.5% | 兆彩製藥發佈了對Pirtobrutinib的第三階段BRUIN CLL-321試驗的結果;該研究的主要終點無進展生存期在主要分析中達成;宣佈了150億的股票回購計劃,以及15%的股息增加

ORCL: -10% | Oracle shares are trading lower following worse-than-expected Q2 financial results.

ORCL: -10% | Oracle的股價在第二季度財務結果不及預期後下降

QURE: 105% | uniQure Reaches Agreement With FDA On Key Elements Of An Accelerated Approval Pathway For AMT-130

QURE: 105% | uniQure與FDA達成協議,確定AMt-130加速審批路徑的關鍵要素

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論